Navigation Links
UCLA to lead local study center in landmark government study of child health
Date:10/4/2007

The UCLA Center for Healthier Children, Families and Communities has been selected as one of 22 new study centers for the National Childrens Study, a nationwide project designed to assess the effects of environmental and genetic factors on childrens health in the United States. The study center will manage local participant recruitment and data collection for the largest study of child health ever conducted in the United States.

The National Childrens Study is a collaborative effort between the U.S. Environmental Protection Agency and the Department of Health and Human Services (including the National Institute of Child Health and Human Development, the National Institute of Environmental Health Sciences at the National Institutes of Health, and the Centers for Disease Control and Prevention).

This study is big science and it will be one of the most important generators of new knowledge on child and adult health and development ever attempted, said principal investigator Dr. Neal Halfon, professor of pediatrics, public health and public policy at UCLA and director of the UCLA Center for Healthier Children, Families and Communities. It will help children across the U.S. and shape child health guidance, interventions and policy for generations to come.

The National Childrens Study will eventually follow a representative sample of 100,000 children from before birth to age 21, seeking information that will help prevent and treat some of the nations most pressing health problems, including autism, birth defects, diabetes, heart disease and obesity. To better understand the impact of exposures on the developing fetus, infant and child, the study will recruit pregnant women, as well as women who are likely to become pregnant, in order assess environmental health influence during the pre-pregnancy and prenatal period.

The UCLA Center for Healthier Children, Families and Communities is an internationlly distiguished leader
'/>"/>

Contact: Amy Albin
aalbin@mednet.ucla.edu
310-794-8672
University of California - Los Angeles
Source:Eurekalert

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. A Novel Method Of Detection Of High Nuclear Grade Localized Renal Cell Carcinoma
2. Residential Locality, A New Determinant Factor For Weight Gain
3. Local Test Confirms Bird Flu Related Death Of Indonesian Man
4. Local Community Objects to Mental Facility
5. Patient Refuses To Be Treated In Local Hospital Due To The Fear Of Contracting MRSA
6. Hong Kong Citizens Fear over Poisonous Vegetables in Local Markets
7. Radiation Therapy Benefits Younger Men With Localized Prostate Cancer
8. Morning-After Pill At The Local Pharmacy Could Prevent Unwanted Pregnancies
9. MRP of drug to include local tax – Paswa
10. Bird Flu In Zambia-Panic Among Locals
11. Increased Demand For Up-gradation Local Hospital In Tiruchy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2008)...ug. 29 /PRNewswire-FirstCall/ -- Landauer, Inc. (N...ors declared a regular,quarterly cash dividend of ...008. The dividend will be paid on October 3, 2008,... About Landauer, Landauer is the leading provide... and environmental radiation exposure. For more th...
(Date:8/29/2008)...fic obligation reduced from $250 to $19 million, ...oston Scientific,Corporation (NYSE: BSX ) today a... Texas found two patents of Medtronic, Inc. (NYSE:...ng the prosecution of the patents,before the Unite... previously found that certain Boston Scientific b...
(Date:8/29/2008)... Dr. Milton Owens and the Coastal Center for O...ia to provide protection for cash paying patients ...ic community is benefiting. , .... Milton Owens and the Coastal Center for Obesity ...rovide protection for cash paying patients in the ...
(Date:8/29/2008)... Trusted life science software provider allows...ngage via GSA. , Reston, ...erging software engineering firm dedicated to the...ral Services Administration (GSA) Contract. The GS...h the ability to conveniently engage 5AM Solutions...
Breaking Medicine News(10 mins):Health News:Court Rejects Two Medtronic Patents 2Health News:Court Rejects Two Medtronic Patents 3Health News:Coastal Center for Obesity Offers Hispanics Weight Loss Surgery with a Warranty 2Health News:Federal and State Agencies Have Easier Access to 5AM Solutions' Award-Winning Software Services 2
...development at Sandia National Laboratories can id...rax in less than five minutes. //Sandia's Laborato...rted the work. Sandia is a multiprogram laboratory...kheed Martin company, for the U.S. Department of E...
...ng great covenant in dental restorative work, say ... and Technology at Ohio.//This ACP has new physica... researcher at OSU. “It’s more soluble than other ...to the stable dental mineral hydroxyapatite, which...
... and Iceland's National University Hospital, ascer...ses a woman's risk by more than 62 per cent.//Endo... tissue, which is normally found only in the linin...he tissue attaches itself to ligaments and organs ...
...e today are more at risk of developing stomach can...earchers at the University of Newcastle believe th... have robbed it off its anti-cancer agents. The r...h indicates that Aspirin may be effective in fight...
Other Medicine News:
(Date:8/27/2008)...in Parts of Bucks, Delaware, Montgomery,Philadelp...e-USNewswire/ -- After encouraging,results followi...tment of,Environmental Protection will continue it...st the mosquito-borne West Nile virus., Targeted ....m. and,midnight in portions of Bucks, Delaware, M...
(Date:8/27/2008)..., melphalan and prednisone arm demonstrated a, si... complete response -, CAMBRIDGE, Mass., Aug. 27 /...pany today announced the publication of results fr... trial in this week,s edition of the,New England J...nt survival,benefit and a 30 percent complete remi...
(Date:8/27/2008)...7 /-, - Oralair(R) Grasses...acodynamic Study Conducted in an Allergen Challeng... positive results of a new study,conducted in an A...alair(R) Grasses included 86 adult patients expose...nt durations: 1 week, 1 month,2 and 4 months with...
(Date:8/27/2008)...rom BLISS-52 trial, expected by mid-2009 - - Data...fall 2009 -, ROCKVILLE, Md., Aug. 27 /PRNewswire-... HGSI ) today announced it has completed enrollme...wo pivotal Phase 3,randomized clinical trials of L... systemic lupus erythematosus (SLE). Belimumab is ...
Breaking Medicine Technology:DEP to Complete Aerial Mosquito Treatments to Stem West Nile Virus in Southeastern Counties 2DEP to Complete Aerial Mosquito Treatments to Stem West Nile Virus in Southeastern Counties 3New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients 2New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients 3New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients 4New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients 5New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients 6Stallergenes: New Study VO 56 Highly Positive Results Conducted in an Allergen Challenge Chamber 2Stallergenes: New Study VO 56 Highly Positive Results Conducted in an Allergen Challenge Chamber 3Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 2Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 3Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 4Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 5Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 6Hiemstra Approved to Manufacture Medical Devices in New CER 9345 1Hiemstra Approved to Manufacture Medical Devices in New CER 9345 2TeamStaff Receives Nasdaq Determination Letter 9340 1TeamStaff Receives Nasdaq Determination Letter 9340 2TeamStaff Receives Nasdaq Determination Letter 9340 3Arena Pharmaceuticals Announces Positive Phase 1a Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis and Initiates Phase 1b Cli 1178 1Arena Pharmaceuticals Announces Positive Phase 1a Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis and Initiates Phase 1b Cli 1178 2Arena Pharmaceuticals Announces Positive Phase 1a Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis and Initiates Phase 1b Cli 1178 3Arena Pharmaceuticals Announces Positive Phase 1a Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis and Initiates Phase 1b Cli 1178 4Chromosome Abnormalities Raise Risk for Autism 9333 1Chromosome Abnormalities Raise Risk for Autism 9333 2Chromosome Abnormalities Raise Risk for Autism 9333 3Chromosome Abnormalities Raise Risk for Autism 9333 4
...nterior Spinal Implant system. Material that has a...cal bone. The result is an implant that meets the ..., while optimizing the fusion environment through ...omic design with 5 and 10 degrees of lordosis. Min...
...Cage System provides anterior column support for s...ctomies from T1 to L5. The system consists of one ...tacked to a desired height, accommodating various ...lymer material emulates the biomechanical properti...
The primary goals in interbody fusion are to immobilize the affected vertebrae, to restore disc space height and sagittal alignment, and to provide an enviroment for bone fusion between vertebral bod
Flexoscope images are transmitted through sorted fiberglass bundles that record the picture and transmit it to a user's eye. Karl Storz flexoscopes are designed for rough, industrial handling and can
Medicine Products: